KRSA
Korsana Biosciences Inc.
KRSA | NASDAQ
$31.14
+$1.00 (+3.32%)
Nov 2, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.17 | -2.66 | -0.37 | -0.65 | -1.30 | -1.28 |
PEG Ratio | 0.12 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 |
PS Ratio | 1.97 | 4.05 | n/a | 95.99 | 20.28 | 40.52 |
PB Ratio | 0.45 | 0.92 | 0.69 | 2.73 | 1.40 | 1.56 |
P/FCF Ratio | -1.24 | -1.87 | -0.37 | -0.70 | -1.84 | -1.26 |
P/OCF Ratio | -1.24 | -1.87 | -0.37 | -0.70 | -1.84 | -1.28 |
OCF/S Ratio | -159.79 | -216.65 | n/a | -13.67K | -1.1K | -3.16K |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.77 |
Quick Ratio | 5.15 | 5.83 | 3.85 | 1.94 | 4.92 | 3.45 |
Current Ratio | 5.15 | 5.83 | 3.85 | 1.94 | 5 | 3.45 |
Asset Turnover | 0.21 | 0.21 | n/a | 0.02 | 0.06 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | -3.45K | n/a |
Return on Equity | -38.83% | -34.54% | -46.62% | -421.72% | -107.05% | -130.78% |
Return on Assets | -35.33% | -31.93% | -39.35% | -243.81% | -87.05% | -67.43% |
Return on Invested Capital | -54.74% | -40.99% | -114.73% | -177.38% | -114.40% | -77.23% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | n/a | -1.78K% | 100% | -2.36K% |
Net Profit Margin | -170.11% | -152.85% | n/a | -14.84K% | -1.56K% | -3.39K% |
Pretax Profit Margin | -170.11% | -152.85% | n/a | -6.14K% | -1.56K% | -3.39K% |
Operating Profit Margin | -239.78% | -181.40% | n/a | -6.24K% | -1.66K% | -3.54K% |
FCF Margin | -159.79% | -216.65% | n/a | -13.67K% | -1.1K% | -3.22K% |
EBITDA Margin | -170.11% | -152.85% | n/a | -6.12K% | -1.62K% | -3.51K% |
Add to Watchlist
Select watchlists to add or remove KRSA